Search

Your search keyword '"Rubini, Michele"' showing total 227 results

Search Constraints

Start Over You searched for: Author "Rubini, Michele" Remove constraint Author: "Rubini, Michele"
227 results on '"Rubini, Michele"'

Search Results

2. Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness

4. Prioritization of putatively detrimental variants in euploid miscarriages

5. Risorse eterogenee distribuite per la didattica e la ricerca: quali livelli di integrazione?

7. Phenome-wide association study of genetically predicted B vitamins and homocysteine biomarkers with multiple health and disease outcomes: analysis of the UK Biobank

12. Epigenetic Studies for Evaluation of NPS Toxicity: Focus on Synthetic Cannabinoids and Cathinones

17. Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk loci

20. Prioritization of putatively detrimental variants in euploid miscarriages

30. Nonsyndromic cleft palate: An association study at GWAS candidate loci in a multiethnic sample

33. Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

35. Atlante degli Eteromorfismi Cromosomici

36. Meta-analysis Reveals Genome-Wide Significance at 15q13 for Nonsyndromic Clefting of Both the Lip and the Palate, and Functional Analyses Implicate GREM1 As a Plausible Causative Gene

37. Generation and characterization of a transgenic mouse carrying a functional human ?-globin gene with the IVSI-6 thalassemia mutation

38. Ultrastructural analysis of collagen fibril diameter distribution in cleft lip.

39. Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study

40. Meta-analysis Reveals Genome-Wide Significance at 15q13 for Nonsyndromic Clefting of Both the Lip and the Palate, and Functional Analyses Implicate GREM1 As a Plausible Causative Gene

41. Prospective biomarker validation trial evaluating the prognostic role of the combined expression of phospho-insulin growth factor receptor-1 and matrilysin in KRAS (exon 2) wild-type (WT) metastatic colorectal cancer (mCRC) patients treated with FOLFOX-6 plus panitumumab as first-line therapy [PULSE trial (GEMCAD 09-03)].

45. Mechanism of Inflammation in Age-Related Macular Degeneration: An Up-to-Date on Genetic Landmarks

47. Generation and Characterization of a Transgenic Mouse Carrying a Functional Humanβ-Globin Gene with the IVSI-6 Thalassemia Mutation

49. Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip

Catalog

Books, media, physical & digital resources